1 enrolling by invitation, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 1, Terminated 1 |
| Phase 2 | 2 | Enrolling by invitation 1, Terminated 1 |
Follow Genes: new trials by email Literature Review of Genes trials Research Report on Genes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease Busulfan, Tocilizumab, Eltrombopag - Chronic Granulomatous Disease (CGD) | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2025-09-10 | 2026-09-08 |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC) - AIDS-related Lymphoma, HIV Infections | Phase 1 / Phase 2 | Terminated | Universitätsklinikum Hamburg-Eppendorf | 5 | 2008-11-28 | 2022-09-08 |
Acquired Immunodeficiency Syndrome (1) · Granulomatous Disease, Chronic (1) · HIV Infections (1) · Lymphoma (1) · Lymphoma, AIDS-Related (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Universitätsklinikum Hamburg-Eppendorf (1)
Germany (1) · United States (1)
Elizabeth M Kang, M.D. (1) · Nicolaus Kroeger (1)